You have read all your free articles, to continue reading subscribe to read the rest of this content.
NeuroVive Pharmaceutical announces two new research agreements and the appointment of Professor Philippe Gallay, PhD, and Professor Massimo Pinzani, MD, PhD, FRCP, as scientific advisors. The aim of the agreements is to further explore NeuroVive's new drug compounds in development for the treatmeAlready a subscriber Login You have read all…
The company has appointed Dr Lars Nieba as Chief Technology Officer and a member of the executive management team. Dr Nieba brings 20 years of leadership experience in the development of multiple pharmaceutical product candidates and innovative technologies. His role at Nordic Nanovector will be Already a subscriber Login You…
Lundbeck has announced that Anders Gersel Pedersen, Executive Vice President and Head of Research and Development (R&D), will retire after 19 years with the company. Gersel Pedersen joined Lundbeck in 2000 as Vice President of International Clinical Research. He was later appointed Executive Already a subscriber Login You have read…
Cytovation AS, a privately held biotech company developing CyPep-1 for the treatment of skin disorders announces the appointment of Professor Ole-Erik Iversen as Scientific Advisor. Professor Iversen has been Professor of Gynecology & Obstetrics at University of Bergen since 1992, having prevAlready a subscriber Login You have read all your…
